MedTech-related health technology assessments from NIHR in November 2021

23

Dec 2021

The National Institute for Health Research (NIHR) funds valuable independent research for health and social care decision-makers in England. Reports from the Health Technology Assessment (HTA) Programme are published in the NIHR HTA Journal and inform NICE guidance.

In November 2021, three MedTech-related assessments were published in the NIHR HTA Journal:

  • Unicompartmental compared with a total knee replacement (TKR) for patients with multimorbidities, an assessment based on a cohort study using propensity score stratification and inverse probability weighting. There were two stages of the study. At the first stage, the Total or Partial Knee Arthroplasty Trial (TOPKAT) was replicated using propensity score and instrumental variable methods. The aim of the second stage was to compare the risk benefits and cost-effectiveness of unicompartmental knee replacement with TKR surgery in patients with severe systemic morbidity who would have been ineligible for TOPKAT using the validated methods from the first stage. It was concluded that unicompartmental knee replacement was safer and more cost-effective than TKR for patients with severe comorbidity and should be considered the first option for suitable patients;
  • Surgery versus conservative management of stable thoracolumbar fracture, based on feasibility randomized controlled trial (PRESTO), qualitative study, and national survey. Surgical fixation (open spinal surgery with or without spinal fusion or minimally invasive stabilization surgery) was compared with initial conservative management of stable thoracolumbar fractures without spinal cord injury. This study concluded that a full trial is unlikely to be feasible, mainly because of the small number of patients meeting the eligibility criteria;
  • Feasibility and design of a trial regarding the optimal mode of delivery for preterm birth, based on the CASSAVA multiple methods study. This study confirmed evidence was lacking about the optimal mode of delivery for women in preterm labor and found agreement that a trial should be conducted. The CASSAVA project could inform the design of the future randomized trial and indicate how such a trial could be carried out.

See the full details here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First EU issues of both newsletters are available for download free-of-charge.

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).

The latest related news

24

Jan 2023

In December 2022, NHS England launched a consultation on the preliminary 2023/25 NHS Payment Scheme, which is set for two years and will replace the National Tariff Payment System from April 2023. Two new cardiovascular categories (antibacterial envelope, mitral valve repair and replacement devices) are proposed for inclusion in the 2023/24 High Cost Device List (will be updated and reissued for 2024/25). The deadline for comments submission is January 27, 2023.

Read more

20

Jan 2023

In December 2022, the National Institute for Health and Care Research (NIHR) in England released six MedTech-related reports in its Health Technology Assessment (HTA) Journal, which concerned laser therapy in diabetic macular oedema, EarlyCDT Lung blood test, video-assisted thoracoscopic or open lobectomy, urethral slings for stress urinary incontinence, placental growth factor (PlGF) and sFlt-1 tests, and photobiomodulation in the management of oral mucositis. HTA Journal publishes research reports on the effectiveness, costs, and broader impact of health technologies for those who use, manage, and provide care in the NHS and informs National Institute for Health and Care Excellence (NICE) guidance.

Read more

19

Jan 2023

On January 1, 2023, the annual update of the Finnish NordDRG system came into force. There are 947 DRGs in the 2023 DRG system, compared to 930 DRGs in 2022. Among other changes, 34 new DRGs were introduced, including the DRGs in the cardiovascular, endocrine, endoscopy, gastrointestinal, obstetrics and gynecology, orthopedics, peripheral vascular, surgical procedures, and some other fields.

Read more

17

Jan 2023

On December 23, 2022, NHS England published a preliminary 2023/25 NHS Payment Scheme and launched a consultation. NHS Payment Scheme will replace the National Tariff Payment System from April 1, 2023. The deadline for comments submission is January 27, 2023.

Read more

12

Jan 2023

In December 2022, the National Institute for Health and Care Excellence (NICE) published one new Medical Technologies Guidance (Memokath 051 Ureter stent for ureteric obstruction) and one MedTech Innovation Briefing (PromarkerD). Also, two new clinical guidelines were published, and one was updated.

Read more